Framework agreement for the supply of pharmaceutical products
This procurement exercise is intended to establish a framework agreement against which Public Health England would call off their requirements for either potassium iodate or potassium iodide tablets to be held in a stockpile of emergency medicines.
UK-Runcorn: Pharmaceutical products
2013/S 123-210519
Contract notice
Supplies
Directive 2004/18/EC
Section I: Contracting authority
The Secretary of State for Health acting through the Commercial Medicines Unit (part of the Department of Health)
Castle View House, East Lane
For the attention of: Lynne Nichols
WA7 2AA Runcorn
UNITED KINGDOM
E-mail: lynne.nichols@cmu.nhs.uk
Further information can be obtained from: The above mentioned contact point(s)
Specifications and additional documents (including documents for competitive dialogue and a dynamic purchasing system) can be obtained from: The above mentioned contact point(s)
Tenders or requests to participate must be sent to: The above mentioned contact point(s)
Other: Public Procurement
Section II: Object of the contract
Purchase
Main site or location of works, place of delivery or of performance: To a location in England to be notified to the successful bidder(s) following award to framework agreement.
NUTS code
Duration of the framework agreement
Duration in years: 4
Estimated total value of purchases for the entire duration of the framework agreement
Estimated value excluding VAT:
Range: between 6 000 000 and 20 000 000 GBP
Deliveries will be required over a period of 2 years, with an option to extend for up to a further 2 years.
33600000, 33690000, 33651000
Estimated value excluding VAT:
Range: between 6 000 000 and 20 000 000 GBP
Description of these options: Framework agreement has the option to be extended for a period of up to 24months
Section III: Legal, economic, financial and technical information
Please refer to the PQQ evaluation approach document which can be accessed once you have expressed an interest within the Bravo portal under ‘Framework agreement for the supply of thyroid blocking agents’
Description of particular conditions: Information will be contained within the Invitation to Offer
Please refer to the selection criteria contained in the PQQ
Section IV: Procedure
Section VI: Complementary information
1) Submission of expression of interest and procurement specific information
This procurement exercise will be conducted on the eTendering portal at www.cmu.bravosolution.co.uk.
Candidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested), through the eTendering portal as follows:
1.1) If not already registered, Candidates should register on the eTendering portal at https://www.cmu.bravosolution.co.uk and click the link to register:
— accept the terms and conditions and click continue,
— enter your correct business and user details,
— note the username you chose and click “Save” when complete,
— you will shortly receive an email with your unique password (please keep this secure).
1.2) Once registered, candidates must express interest as follows:
a. login to the eTendering portal;
b. select “Response to PQQ”;
c. select “PQQs Open To All Suppliers”;
d. access listing related to this procurement “Framework agreement for the supply of thyroid blocking agents” and view details;
e. click on “Express interest” button at the top of the page.
f. Once you have expressed interest, the PQQ will move to “My PQQs”, where you can download additional documentation (if required), and construct your reply as instructed. You must then publish your reply using the “Publish” button.
1.3) For any support in registering on the portal or submitting your expression of interest please contact the eTendering Help-desk at +44 800 368 4850 or help@bravosolution.co.uk.
2) General supplier information.
To manage and assess supplier information the Contracting Authority requests candidates provide their company profile in the Governments supplier information database, sid4gov, as follows:
2.1) If not already registered, Candidates must go to the following web page https://sid4gov.cabinetoffice.gov.uk/ and select “Register for sid4gov” at the bottom of the page. Key in details as requested to search for your company. If you do not have a D-U-N-S® Number, click on the link at the right of the page to obtain a number from D&B. Candidates must obtain a Dun & Bradstreet (D&B) D-U-N-S® Number to enable registration on sid4gov.
2.2) Once registration is complete you are able to create and update your sid4gov company profile. Candidates should ensure all the mandatory fields of their sid4gov profile are completed and up to date for each procurement exercise. D&B data will be supplied automatically by D&B.
2.3) For further help or information concerning sid4gov, please contact the sid4gov Helpdesk at: support@nqc.com or telephone +44 (0) 845 299 2994.
The framework agreement is for the benefit of the Authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom and Crown Dependencies including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers.
Contracts awarded under a framework agreement may be awarded either: a) by application of the terms laid down in the framework agreement without reopening competition, or b) where not all the required terms of the proposed contracts are laid down in the framework agreement, by reopening competition between the economic operators which are parties to this framework agreement and which are capable of performing the proposed contract. Reopening of competition will be done in accordance with the procedure set out in Directive 2004/18/EC, Article 32.
Potential suppliers should note that, in accordance with the Government’s policies on transparency, the Contracting Authority intends to publish the OJEU, ITO and the text of final contracts / framework agreements, subject to possible redactions at the discretion of the CMU (part of the Department of Health). Further information on transparency can be found at: http://www.cabinetoffice.gov.uk/resource-library/guidance-transparency.
VI.5)Date of dispatch of this notice:24.6.2013